+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
ID07227298

Study Evaluating Safety and Preliminary Effects of PF-08634404 Combined with Different Cancer Medicines in Advanced Solid Tumors

Led by Pfizer · Updated on 2026-10-08

162

Participants Needed

104

Research Sites

232 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new medicine called PF-08634404 to learn how it works when combined with other cancer medicines in people with advanced solid tumors that cannot be removed by surgery or cured with standard treatments. This study focuses on participants aged 18 and older who have advanced non-small cell lung cancer NSCLC that has spread to other parts of the body. The study aims to assess the safety of PF-08634404 with other cancer medicines, observe possible side effects, and evaluate the treatments potential to help control these tumors. Participants will receive PF-08634404 combined with different anticancer agents during two main parts of the study. Part A tests PF-08634404 with Sigvotatug Vedotin, and Part B tests it with PF-08046054SGN-PDL1V. All study medicines are given through intravenous IV infusions at clinical trial sites, where trained medical staff will monitor participants during and after each visit. Throughout the study, participants will undergo regular assessments including monitoring for treatment-related side effects and serious adverse events up to 90 days after the last treatment. Researchers will also measure tumor response using imaging and clinical evaluations up to about five years. Additional tests will check laboratory abnormalities, drug levels in the blood, and immune responses to the medicine. Participants are monitored closely during visits to track safety and treatment effects.

CONDITIONS

Brief Title

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Research Team

P

Pfizer CT.gov Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here